Dr. Nan Fang

Dr. Nan Fang is the Chair, CEO, and Co-founder of Singleron Biotechnologies, a pioneering life science tools company specializing in single-cell multi-omics technologies. Founded in 2018, Singleron has rapidly become one of the leading single cell multi-omics solution providers and expanded its global presence with operations in Germany, the United States, China, and Singapore, offering comprehensive solutions for research, clinical applications, and drug development. Dr. Fang holds a Ph.D. in Immunology from the University of Iowa, an MBA from Julius-Maximilians-Universität Würzburg, and an Bachelor of Science in Biology from the University of Science & Technology of China